KonstantinosArnaoutakisMD

Clinical Trials

• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14

  Completed

  Phase 2

• Vaccination of Advanced-Stage Lung Cancer Patients Start of enrollment: 2015 Oct 01

  Withdrawn

  Phase 1, Phase 2

• A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine Start of enrollment: 2015 Aug 01

  Completed

  Not Applicable

• A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine Start of enrollment: 2016 Jan 01

  Active, not recruiting

  Not Applicable

• Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01

  Completed

  Phase 2

• Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01

  Completed

  Phase 2, Phase 3

• Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29

  Active, not recruiting

  Phase 3

• Join now to see all